# Vivianne C. G. Tjan‐Heijnen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vivianne-c-g-tjan-heijnen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,445 |
| Field | Breast Cancer Treatment Studies |
| h-index | 65 |
| i10-index | 223 |
| Last Known Institution | Maastricht University Medical Centre |
| OpenAlex ID | https://openalex.org/A5054754505 |
| ORCID iD | https://orcid.org/0000-0002-3935-7440 |
| Works | 430 |

## Researcher papers

- [Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials](https://scholariq.org/papers/increasing-the-dose-intensity-of-chemotherapy-by-more-frequent-administration-or/)
- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Maastricht University Medical Centre](https://scholariq.org/institutions/maastricht-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.